Skip to main content

schizophrenia Archives

New drug-like molecules could improve schizophrenia treatment

Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.

Read more


New insight into impulse control

Aug. 30, 2011—How the brain is wired to control impulsive behavior differs significantly from what psychologists have thought, new research finds.

Read more


Connecting the dots in schizophrenia

Jul. 29, 2011—Abnormalities of the hippocampus, a seahorse-shaped brain region involved in learning and memory, may play a role in the psychotic symptoms and cognitive deficits of schizophrenia.

Read more


Why people with schizophrenia may have trouble reading social cues

May. 24, 2011—Impairments in a brain area involved in social perception may help explain why individuals with schizophrenia have trouble reading social cues.

Read more


Neuroscience drug discovery center opens at Vanderbilt

Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.

Read more


Schizophrenics better at some memory tasks

Jan. 28, 2011—Individuals with schizophrenia are better at some cognitive tasks than average people, new research from Vanderbilt University indicates. The findings open the door for potential new therapies for these individuals. “We found a pocket of spared or enhanced ability in patients with schizophrenia when almost everything else is impaired,” Vanderbilt psychologist Sohee Park, co-author of...

Read more


How universities can help fill the “pipeline” with important new drugs

Jan. 27, 2011—Bringing a new drug to market is an increasingly daunting – and expensive – task. Today it costs more than $1 billion and takes more than seven years, on average, to complete the human studies required for a drug to be approved for marketing. Only about one in five drugs makes it through the clinical...

Read more


Page 4 of 41234